AI in Dental Practices: What Principal Dentists and Groups Should Evidence

Dental practices are increasingly exposed to AI through imaging tools, note drafting, transcription, patient communication, marketing automation, ChatGPT, Copilot and AI-enabled admin systems. The governance question is whether the practice can show which AI tools are being used, whether patient data is involved, whether patients are informed, whether data-protection risks have been assessed and whether clinicians remain accountable for final decisions and records.

Who this is for

  • Principal dentists
  • Dental practice managers
  • Dental groups
  • Implant clinics
  • Orthodontic practices
  • DPOs and governance leads

Where AI may appear in dentistry

Checklist

  • AI imaging tools
  • Radiograph support
  • Intraoral scan analysis
  • Note drafting
  • Clinical transcription
  • Patient communications
  • Marketing automation
  • ChatGPT or Copilot use
  • Supplier platform AI features

Evidence the practice may need

Checklist

  • AI tool and use-case inventory
  • Patient-data exposure note
  • DPIA screening record
  • Vendor DPAs
  • Hosting and data residency confirmation
  • Retention and deletion terms
  • Patient transparency wording
  • Clinician review workflow
  • Staff guidance
  • Indemnity / insurer disclosure-readiness indicators

Common evidence gaps

Checklist

  • AI imaging supplier evidence not held centrally
  • Staff using ChatGPT or Copilot without a written patient-data boundary
  • Transcription tools used without DPIA screening
  • Patient transparency wording inconsistent
  • Marketing AI not clearly separated from clinical data
  • No approved/prohibited AI use policy

What ELSA AI can help produce

The Diagnostic gives dental groups the same board-ready evidence pack structure as other private providers.

Outputs include

  • Board / Principal Dentist Findings Report
  • RAG Exposure Map
  • AI Tool and Use Case Inventory
  • DPIA Readiness and Patient Data Exposure Note
  • Vendor Data Position and Evidence Tracker
  • MDO / Indemnity / Insurer Disclosure Readiness Note
  • 30-Day Priority Action Plan

The issue is not simply that AI tools exist. The issue is having no documented governance position when someone asks how that AI use is controlled. Clinical AI Exposure Diagnostic™ page explains scope, timeline and fees.

Advisory governance support only. Not legal advice, DPIA sign-off, CQC certification, ICO approval, insurer coverage advice, MDO indemnity advice or clinical safety case sign-off. Final decisions remain with the clinic’s accountable officers and advisers.

Need this evidence mapped for your clinic?

The Clinical AI Exposure Diagnostic™ gives clinic leadership a board-ready view of AI use, patient-data exposure, evidence gaps and priority actions in four working days from completed intake.

Related guides